Internal Medicine, Rheumatology · Summerfield, FL
NPI
1508008228
Since 2009
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10250 SE 167th Place Rd, Suite 5
Summerfield, FL, 34491
Phone (352) 307-9925
Groups this clinician bills Medicare through
Medicare paid, 2024
$638K
87,592 services
Medicare patients, 2024
368
Average age 75
Drug cost, 2024
$9.6M
5,157 prescriptions
Company payments, 2025
$2,135
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hasan Abualula was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 66,402 times for 19 patients. In total Hasan Abualula billed 87,592 services in 59 codes, and Medicare paid $638K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 66,402 | 19 | $3.63 | $241K |
| J0897 Injection, denosumab, 1 mg | Office | 2,700 | 33 | $20.43 | $55K |
| 99214 Office E&M - Established | Office | 473 | 260 | $87.21 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 369 | 234 | $12.74 | $4,701 |
| 96401 Chemotherapy Administration | Office | 334 | 19 | $53.42 | $18K |
| 36415 Venipuncture Blood Collection | Office | 324 | 196 | $8.65 | $2,803 |
| 85025 Blood Count | Office | 262 | 163 | $7.61 | $1,994 |
| 80053 Clinical Chemistry | Office | 261 | 158 | $10.35 | $2,701 |
| 85652 Clinical Chemistry | Office | 250 | 152 | $2.65 | $663 |
| 99204 Office E&M - New | Office | 95 | 95 | $106.67 | $10K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 91 | 17 | $0.52 | $47.46 |
| 96365 Intravenous Infusion, Hydration | Office | 86 | 16 | $46.82 | $4,027 |
| 96372 Injection Administration | Office | 76 | 42 | $10.63 | $808 |
| 82306 Clinical Chemistry | Office | 55 | 43 | $29.01 | $1,596 |
| 83721 Clinical Chemistry | Office | 35 | 27 | $10.29 | $360 |
By year: 2022 $930K for 111,203 services; 2023 $973K for 118,288 services; 2024 $638K for 87,592 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 324 | 196 | $8.65 | $2,803 |
| 85025 Blood Count | 262 | 163 | $7.61 | $1,994 |
| 80053 Clinical Chemistry | 261 | 158 | $10.35 | $2,701 |
| 85652 Clinical Chemistry | 250 | 152 | $2.65 | $663 |
| 82306 Clinical Chemistry | 55 | 43 | $29.01 | $1,596 |
| 80061 Clinical Chemistry | 35 | 27 | $13.12 | $459 |
| 83721 Clinical Chemistry | 35 | 27 | $10.29 | $360 |
| 84443 Clinical Chemistry | 33 | 27 | $16.46 | $543 |
| 84439 Clinical Chemistry | 21 | 18 | $8.84 | $186 |
| 84550 Clinical Chemistry | 17 | 14 | $4.43 | $75.31 |
Medicare prescription drug claims, 2024
In 2024, the drug Hasan Abualula prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 926 prescriptions and refills. In total Hasan Abualula wrote 5,157 Medicare prescriptions that cost $9.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 926 | 2,355 | 301 | $25K |
| Hydroxychloroquine Sulfate Generic | 678 | 1,830 | 235 | $24K |
| Leflunomide Generic | 418 | 1,118 | 148 | $40K |
| Prednisone Generic | 354 | 934 | 155 | $3,426 |
| Rinvoq Upadacitinib | 261 | 273 | 35 | $1.7M |
| Sulfasalazine Generic | 248 | 681 | 104 | $9,626 |
| Humira(Cf) Pen Adalimumab | 224 | 226 | 32 | $1.7M |
| Folic Acid Generic | 212 | 632 | 84 | $1,548 |
| Methylprednisolone Generic | 210 | 278 | 153 | $3,069 |
| Enbrel Mini Etanercept | 164 | 164 | 20 | $1.2M |
| Enbrel Sureclick Etanercept | 114 | 123 | 16 | $924K |
| Allopurinol Generic | 103 | 296 | 36 | $1,286 |
| Otezla Apremilast | 102 | 102 | Under 11 | $497K |
| Xeljanz Xr Tofacitinib Citrate | 98 | 98 | 15 | $560K |
| Orencia Clickject Abatacept | 82 | 82 | Under 11 | $480K |
Brand drugs: - claims; generic drugs: 3,410 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hasan Abualula $2,135 ($2,135 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $476.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $476 |
| Janssen Biotech, Inc. JNJ | 18 | $384 |
| Amgen Inc. AMGN | 17 | $306 |
| Pfizer Inc. PFE | 15 | $220 |
| Lilly USA, LLC LLY | 8 | $183 |
| GlaxoSmithKline, LLC. GSK | 8 | $162 |
| UCB, Inc. UCB.BR | 5 | $129 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $100 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $54.63 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $45.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.